Siri A Eikeland
Overview
Explore the profile of Siri A Eikeland including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gulbrandsen M, Noding A, Smeland K, Eikeland S, Kiserud C, Hjermstad M, et al.
Leuk Lymphoma
. 2023 May;
64(6):1139-1150.
PMID: 37144290
High-dose chemotherapy with autologous stem cell transplantation (HDT-ASCT) is the preferred treatment option in relapsed or refractory Hodgkin lymphoma (HL). We analyzed the association between treatment intensity and health-related quality...
2.
Eikeland S, Smeland K, Simensen V, Fagerli U, Bersvendsen H, Kiserud C, et al.
Acta Oncol
. 2023 Jan;
62(1):80-88.
PMID: 36715320
Background: Chronic fatigue (CF), substantial fatigue for ≥ six months, can manifest as a late effect (LE) after cancer treatment, and may affect several aspects of life. In a Norwegian...
3.
Eikeland S, Smeland K, Brekke M, Kiserud C, Fossa A
Scand J Prim Health Care
. 2022 Nov;
40(3):360-369.
PMID: 36380478
Objective: With increasing cancer incidence and survival rates, follow-up care becomes a major healthcare concern, placing increased demands on general practitioners (GPs). We explored GPs' awareness of late effects (LEs)...
4.
Eikeland S, Smeland K, Mols F, Fagerli U, Bersvendsen H, Kiserud C, et al.
Acta Oncol
. 2021 Apr;
60(7):911-920.
PMID: 33905285
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting side effect of Hodgkin's lymphoma (HL) treatment. We aimed to describe the prevalence of CIPN associated symptoms in long-term HL survivors compared...